Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Epithelial–Mesenchymal Transition in Non Small-cell Lung Cancer

NIKOLAOS TSOUKALAS, ELENI ARAVANTINOU-FATOROU, MARIA TOLIA, CONSTANTINOS GIAGINIS, MICHAIL GALANOPOULOS, MARIA KIAKOU, IOANNIS D. KOSTAKIS, EUGENE DANA, IOANNIS VAMVAKARIS, ATHANASIOS KOROGIANNOS, EVANGELOS TSIAMBAS, NIKOLAOS SALEMIS, GEORGE KYRGIAS, ANDREAS KARAMERIS and STAMATIOS THEOCHARIS
Anticancer Research April 2017, 37 (4) 1773-1778;
NIKOLAOS TSOUKALAS
1Department of Oncology, Veterans Hospital (NIMTS), Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: tsoukn@yahoo.gr
ELENI ARAVANTINOU-FATOROU
2251 Air Force Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARIA TOLIA
3Department of Radiotherapy-Radiation Oncology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CONSTANTINOS GIAGINIS
4First Department of Pathology, Medical School, University of Athens, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MICHAIL GALANOPOULOS
5401 General Military Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARIA KIAKOU
5401 General Military Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
IOANNIS D. KOSTAKIS
5401 General Military Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EUGENE DANA
4First Department of Pathology, Medical School, University of Athens, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
IOANNIS VAMVAKARIS
4First Department of Pathology, Medical School, University of Athens, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ATHANASIOS KOROGIANNOS
4First Department of Pathology, Medical School, University of Athens, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EVANGELOS TSIAMBAS
5401 General Military Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NIKOLAOS SALEMIS
5401 General Military Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GEORGE KYRGIAS
3Department of Radiotherapy-Radiation Oncology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANDREAS KARAMERIS
6Department of Pathology, Veterans Hospital (NIMTS), Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STAMATIOS THEOCHARIS
4First Department of Pathology, Medical School, University of Athens, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: Lung cancer is the first cause of cancer related deaths in both males and females. Epithelial–mesenchymal transition (EMT) is a reversible process by which epithelial cells transform to mesenchymal stem cells by losing their cell polarity and cell-to-cell adhesion, gaining migratory and invasive properties. High levels of E-cadherin are expressed in epithelial cells, whereas mesenchymal cells express high levels of N-cadherin, fibronectin and vimentin. The aim of this study was to evaluate the correlation between E-cadherin and vimentin expression and their clinical significance in non-small cell lung cancer (NSCLC). Materials and Methods: The immunohistochemical expression of E-cadherin, vimentin and Ki-67 was performed on tissue microarrays from NSCLC specimens obtained from 112 newly- diagnosed cases and were studied using classical pathological evaluation. Associations between E-cadherin, vimentin and Ki-67 expression, clinicopathological variables and survival were analyzed. In all cases, a value of p≤0.05 was considered significant. Results: Low E-cadherin expression was significantly correlated with tumor necrosis (p=0.019). Moreover, there was a trend for correlation between high E-cadherin expression and better overall survival (hazard ratio=1.02, and 95% confidence interval=0.45-1.87, p=0.091). There was also a significant negative correlation between vimentin expression and overall survival (hazard ratio=1.13, and 95% confidence interval=0.78-1.65, p=0.026). Additionally, there was a significant negative correlation between vimentin expression and grade I tumors (p=0.031). Finally, a positive correlation trend between vimentin expression and Ki-67 was found (p=0.073). Conclusion: High E-cadherin and low vimentin expression correlate with better prognosis and overall survival.

  • E-Cadherin
  • vimentin
  • epithelial mesenchymal transition (EMT)
  • non-small-cell lung cancer (NSCLC)
  • biomarker
  • prognosis

Footnotes

  • ↵* These Authors contributed equally to this study.

  • This article is freely accessible online.

  • Conflicts of Interest

    No potential conflicts of interest exist. No financial support was granted.

  • Received February 16, 2017.
  • Revision received March 20, 2017.
  • Accepted March 21, 2017.
  • Copyright© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved
View Full Text
PreviousNext
Back to top

In this issue

Anticancer Research: 37 (4)
Anticancer Research
Vol. 37, Issue 4
April 2017
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Epithelial–Mesenchymal Transition in Non Small-cell Lung Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Epithelial–Mesenchymal Transition in Non Small-cell Lung Cancer
NIKOLAOS TSOUKALAS, ELENI ARAVANTINOU-FATOROU, MARIA TOLIA, CONSTANTINOS GIAGINIS, MICHAIL GALANOPOULOS, MARIA KIAKOU, IOANNIS D. KOSTAKIS, EUGENE DANA, IOANNIS VAMVAKARIS, ATHANASIOS KOROGIANNOS, EVANGELOS TSIAMBAS, NIKOLAOS SALEMIS, GEORGE KYRGIAS, ANDREAS KARAMERIS, STAMATIOS THEOCHARIS
Anticancer Research Apr 2017, 37 (4) 1773-1778;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Epithelial–Mesenchymal Transition in Non Small-cell Lung Cancer
NIKOLAOS TSOUKALAS, ELENI ARAVANTINOU-FATOROU, MARIA TOLIA, CONSTANTINOS GIAGINIS, MICHAIL GALANOPOULOS, MARIA KIAKOU, IOANNIS D. KOSTAKIS, EUGENE DANA, IOANNIS VAMVAKARIS, ATHANASIOS KOROGIANNOS, EVANGELOS TSIAMBAS, NIKOLAOS SALEMIS, GEORGE KYRGIAS, ANDREAS KARAMERIS, STAMATIOS THEOCHARIS
Anticancer Research Apr 2017, 37 (4) 1773-1778;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Breast cancer progression and metastasis to lymph nodes reveals cancer cell plasticity and MHC class II-mediated immune regulation
  • Magnolol Induces Apoptosis Through Extrinsic/intrinsic Pathways and Attenuates NF-{kappa}B/STAT3 Signaling in Non-small-cell Lung Cancer Cells
  • Vimentin overexpression as a novel poor prognostic biomarker in eyelid sebaceous gland carcinoma
  • Clinical and Prognostic Significance of Neoplastic Spindle Cells in Gallbladder Cancer
  • The Mesenchymal-Epithelial and Epithelial-Mesenchymal Cellular Plasticity of Liver Metastases with Digestive Origin
  • NHERF1 Suppresses Lung Cancer Cell Migration by Regulation of Epithelial-Mesenchymal Transition
  • Google Scholar

More in this TOC Section

  • Kisspeptin Retards Tumor Growth of Lewis Lung Carcinoma Cells Through p38 MAPK-mediated Senescence
  • Epigenetic Modification of Muscarinic Acetylcholine Receptors in Squamous Cell Carcinoma of the Head and Neck
  • Circular RNA hsa_circ_0004650 Enhances 5-Fluorouracil Resistance in Gastric Cancer via Sponging miR-145-5p
Show more Experimental Studies

Similar Articles

Keywords

  • E-cadherin
  • vimentin
  • epithelial mesenchymal transition (EMT)
  • non-small-cell lung cancer (NSCLC)
  • biomarker
  • prognosis
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire